24-hydroxycholesterol moderates the effects of amyloid-β on expression of HMG-CoA reductase and ABCA1 proteins in mouse astrocytes
Background: Elevated brain cholesterol increases the risk of Alzheimer's disease. Production of 24-hydroxycholesterol (24s-OHC) by neurons prevents cholesterol accumulation in the brain. In this study, we investigated the effect of 24s-OHC on the HMG-COA reductase and ABCA1 which are involved i...
Main Authors: | Zahra Nazeri, Ghorban Mohammadzadeh, Mojtaba Rashidi, Shirin Azizdoost, Maryam Cheraghzadeh, Alireza Kheirollah |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Advanced Biomedical Research |
Subjects: | |
Online Access: | http://www.advbiores.net/article.asp?issn=2277-9175;year=2023;volume=12;issue=1;spage=167;epage=167;aulast=Nazeri |
Similar Items
-
HMG-CoA reductase is a potential therapeutic target for migraine: a mendelian randomization study
by: Kang Qu, et al.
Published: (2024-05-01) -
In silico approach for identification of potential tetracyclic triterpenoids from mushroom as HMG-CoA reductase inhibitor
by: Rishav Mazumder, et al.
Published: (2024-12-01) -
Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients
by: Esmat Khaleqsefat, et al.
Published: (2025-01-01) -
Lepidopteran HMG-CoA reductase is a potential selective target for pest control
by: Yuan-mei Li, et al.
Published: (2017-01-01) -
Induction of the intestinal membrane transporters ABCA1 and ABCG8 by 27-hydroxycholesterol through a redox mechanism
by: Noemi Iaia, et al.
Published: (2024-08-01)